Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug;48(4):2051-2068.
doi: 10.1007/s11259-024-10432-x. Epub 2024 Jun 13.

A review on camelid nanobodies with potential application in veterinary medicine

Emadodin Tohidi  1 , Mehran Ghaemi  2 , Mohammad Sadegh Golvajouei  3
Affiliations
Review

A review on camelid nanobodies with potential application in veterinary medicine

Emadodin Tohidi et al. Vet Res Commun. 2024 Aug.

Abstract

The single variable domains of camelid heavy-chain only antibodies, known as nanobodies, have taken a long journey since their discovery in 1989 until the first nanobody-based drug's entrance to the market in 2022. On account of their unique properties, nanobodies have been successfully used for diagnosis and therapy against various diseases or conditions. Although research on the application of recombinant antibodies has focused on human medicine, the development of nanobodies has paved the way for incorporating recombinant antibody production in favour of veterinary medicine. Currently, despite many efforts in developing these biomolecules with diversified applications, significant opportunities exist for exploiting these highly versatile and cost-effective antibodies in veterinary medicine. The present study attempts to identify existing gaps and shed light on paths for future research by presenting an updated review on camelid nanobodies with potential applications in veterinary medicine.

Keywords: Antibodies; Heavy-chain only; Low-cost; Recombinant; Single variable domains; Versatile.

PubMed Disclaimer

References

    1. Abbady AQ, Al-Mariri A, Zarkawi M, Al-Assad A, Muyldermans S (2011) Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel. Vet Immunol Immunopathol 142(1–2):49–56. https://doi.org/10.1016/j.vetimm.2011.04.004 - DOI - PubMed
    1. Abeijon C, Dilo J, Tremblay JM, Viana AG, Bueno LL, Carvalho SF, Fujiwara RT, Shoemaker CB, Campos-Neto A (2018) Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis. Parasite Immunol 40(11):e12584. https://doi.org/10.1111/pim.12584 - DOI - PubMed - PMC
    1. Arbabi-Ghahroudi M (2022) Camelid single-domain antibodies: promises and challenges as lifesaving treatments. Int J Mol Sci 23(9):5009. https://doi.org/10.3390/ijms23095009 - DOI - PubMed - PMC
    1. Arce LP, Pavan MF, Bok M, Gutiérrez SE, Estein SM, Santos AT, Condorí WE, Uhart MM, Parreño V, Vizoso-Pinto MG, Ibañez LI (2023) A multispecies competitive nanobody-based ELISA for the detection of antibodies against hepatitis E virus. Sci Rep 13(1):15448. https://doi.org/10.1038/s41598-023-41955-z - DOI - PubMed - PMC
    1. Ardekani LS, Gargari SLM, Rasooli I, Bazl MR, Mohammadi M, Ebrahimizadeh W, Bakherad H, Zare H (2013) A novel nanobody against urease activity of Helicobacter pylori. Int J Infect Dis 17(9):e723–e728. https://doi.org/10.1016/j.ijid.2013.02.015 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources